WS #12212
European Commission approved once-daily Wegovy pill, first oral GLP-1 treatment for weight management in the EU, a landmark for obesity care. UnitedHealth reported Q2 adjusted EPS of $6.38 on revenue of $112.03B, beating estimates; raised 2026 adjusted EPS guidance to $19.50-$20. US to impose 25% tariffs on thousands of Brazilian imports including sugar, apparel, paper, and steel, effective July 22.
EU Approves Oral GLP-1 Wegovy Pill
European Commission approved once-daily Wegovy pill, first oral GLP-1 treatment for weight management in the EU, a landmark for obesity care.
UnitedHealth reported Q2 adjusted EPS of $6.38 on revenue of $112.03B, beating estimates; raised 2026 adjusted EPS guidance to $19.50-$20.
US to impose 25% tariffs on thousands of Brazilian imports including sugar, apparel, paper, and steel, effective July 22.